<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>32</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Higgins, Adam Z.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Medical Research and the Ethics of Distribution: Nisin-treated Catheters in Ecuador and Oregon</style></title><secondary-title><style face="normal" font="default" size="100%">bioengineering</style></secondary-title><tertiary-title><style face="normal" font="default" size="100%">Bothwell, Michelle</style></tertiary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">antimicrobial</style></keyword><keyword><style  face="normal" font="default" size="100%">Bioengineering</style></keyword><keyword><style  face="normal" font="default" size="100%">catheter</style></keyword><keyword><style  face="normal" font="default" size="100%">Ecuador</style></keyword><keyword><style  face="normal" font="default" size="100%">oregon</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2002</style></year><pub-dates><date><style  face="normal" font="default" size="100%">06/2002</style></date></pub-dates></dates><publisher><style face="normal" font="default" size="100%">Oregon State University</style></publisher><pub-location><style face="normal" font="default" size="100%">Corvallis</style></pub-location><volume><style face="normal" font="default" size="100%">Bachelor of Arts in International Studies in Bioengineering</style></volume><pages><style face="normal" font="default" size="100%">72</style></pages><abstract><style face="normal" font="default" size="100%">There is a large disparity in health care access and research funding between
nations, which affects the distribution of new medical technologies and brings to bear
issues of distributive justice. The financial aspects of new medical developments should
be considered by researchers who aim to improve health since affordability plays a major
role in the extent of positive health effects that an innovation can produce. Over the last
decade, researchers at Oregon State University have developed a new method for 
reducing the incidence of catheter-related infection. Catheters are treated with the
antimicrobial peptide nisin, which prevents bacterial adhesion and subsequent infection.
The potential for use of nisin-treated catheters in Ecuador and Oregon was examined,
focusing on economic constraints that could affect the distribution of treated catheters. It
was found that nisin-treated catheters may actually reduce cost by reducing the length of
hospital stay associated with catheter-related infection. Thus, nisin-treated catheters
would be affordable in both Ecuador and Oregon and problems of inequitable distribution
based on economics would not be present with the introduction of this technology.
</style></abstract><work-type><style face="normal" font="default" size="100%">Undergraduate</style></work-type></record></records></xml>